A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : ctDNA

Search Conditions:
Search Keyword : ctDNA
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: ctDNA
Appearance Frequency: 852 time(s)
Long forms: 17

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
circulating tumor DNA
(713 times)
Neoplasms
(355 times)
NSCLC (95 times)
NGS (84 times)
CTCs (78 times)
2008 Circulating mutant DNA to assess tumor dynamics.
chloroplast DNA
(46 times)
Genetics
(18 times)
mtDNA (6 times)
nDNA (4 times)
CMS (3 times)
1975 Denaturation mapping studies on the circular chloroplast deoxyribonucleic acid from pea leaves.
cell-free tumor DNA
(34 times)
Neoplasms
(20 times)
NSCLC (6 times)
EGFR (5 times)
cfDNA (4 times)
2014 Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.
calf thymus deoxyribonucleic acid
(26 times)
Molecular Biology
(10 times)
CD (3 times)
AO (2 times)
HSA (2 times)
2006 [Study on surface-capped CdS nanoparticles as fluorescence probes].
circulating tumor-derived DNA
(10 times)
Neoplasms
(6 times)
cfDNA (2 times)
EGFR (2 times)
ARMS (1 time)
2012 Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.
circulating DNA
(7 times)
Biochemistry
(2 times)
CRC (2 times)
CTCs (1 time)
ER (1 time)
2010 Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.
circulating tumor deoxyribonucleic acid
(3 times)
Neoplasms
(1 time)
CCND1 (1 time)
CTC (1 time)
CV (1 time)
2017 Utilizing Tumor and Plasma Liquid Biopsy in Treatment Decision Making for an Estrogen Receptor-Positive Advanced Breast Cancer Patient.
Circulating tumor-derived cell-free DNA
(3 times)
Science
(2 times)
ccfDNA (1 time)
CTCs (1 time)
2018 Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
cells or tumor DNA
(2 times)
Neoplasms
(2 times)
MAP (1 time)
2016 Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital.
10  cell tumor DNA
(1 time)
Gastroenterology
(1 time)
cfDNA (1 time)
CTCs (1 time)
GC (1 time)
2016 New blood markers detection technology: A leap in the diagnosis of gastric cancer.
11  cell-free DNA from tumours in blood
(1 time)
Neoplasms
(1 time)
--- 2017 The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review.
12  cell-free, tumor-associated BRAF(mutant) and NRAS(mutant) DNA
(1 time)
Molecular Biology
(1 time)
ddPCR (1 time)
2016 Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.
13  chloroplast deoxyribonucleic acid
(1 time)
Biochemistry
(1 time)
RNA (1 time)
1981 Messenger ribonucleic acid transcripts of pea chloroplast deoxyribonucleic acid.
14  chloroplast genomic DNA
(1 time)
Molecular Biology
(1 time)
aDNA (1 time)
DNA (1 time)
mtDNA (1 time)
2014 DNA extraction from rice endosperm (including a protocol for extraction of DNA from ancient seed samples).
15  combined analysis of tissue and blood
(1 time)
Neoplasms
(1 time)
mCRC (1 time)
SISH (1 time)
2017 Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.
16  conformation trends to target
(1 time)
Biochemistry
(1 time)
--- 2019 Electrochemical, spectroscopic and molecular docking studies on the interaction of calcium channel blockers with dsDNA.
17  plasma-circulating tumor DNA
(1 time)
Neoplasms
(1 time)
CTCs (1 time)
FFPE (1 time)
2018 ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment.